Jaundice Phototherapy Bed Market Overview
The Jaundice Phototherapy Bed Market is expanding as the incidence of neonatal jaundice increases and healthcare providers seek effective, comfortable, and technologically advanced treatment solutions. Rising awareness of neonatal healthcare, increasing healthcare expenditure, advancements in phototherapy technology, and growing demand for home-based treatment are supporting market growth.
According to the WiseGuyReports market report published in August 2026, the global Jaundice Phototherapy Bed Market was valued at USD 500 Million in 2024 and USD 500 Million in 2025 and is projected to reach USD 1.2 Billion by 2035, registering a CAGR of 9.1% during 2026–2035. North America held the largest regional position, valued at USD 150 Million in 2024 and projected to reach USD 360 Million by 2035. Neonatal Jaundice represented the leading application segment, valued at USD 250 Million in 2024 and projected to reach USD 600 Million by 2035.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/sample-request?id=618865
Key players driving innovation and competitiveness in the Jaundice Phototherapy Bed Market include:
Zoll Medical
Hiteshi
Medela
Philips Healthcare
Dräger
Sunshine Medical
Atom Medical Corporation
Miris
Bistos
Cleo Medical
Natus Medical
Boram Medical
Phoenix Medical Systems
GE Healthcare
Dixion
Weyer GmbH
The market is being shaped by the increasing prevalence of neonatal jaundice, growing awareness of early diagnosis and treatment, and advancements in phototherapy systems. LED-based technologies are gaining attention because of their energy efficiency, lower heat emission, and effective light delivery. Portable and compact phototherapy systems are also gaining traction as healthcare providers increasingly consider home care and flexible treatment options.
The Jaundice Phototherapy Bed Market can be segmented by Application into Neonatal Jaundice, Adult Jaundice, and Chronic Jaundice. By Type, it includes Standard Phototherapy Beds, Portable Phototherapy Beds, and Combo Phototherapy Units. By End Use, it covers Hospitals, Clinics, and Home Care. By Technology, it includes LED Phototherapy, Fluorescent Phototherapy, and Halogen Phototherapy. Regionally, the market covers North America, Europe, South America, Asia Pacific, and the Middle East and Africa.
The growing need for effective jaundice treatment is creating opportunities for medical-device manufacturers, neonatal care providers, hospitals, clinics, and healthcare technology companies. Smart phototherapy beds, real-time monitoring, portable treatment systems, energy-efficient technologies, and telemedicine-enabled care can support market differentiation and future growth.
Recent Developments and Market Trends:
LED-based phototherapy systems are gaining adoption because of their energy efficiency and ability to provide effective treatment with lower heat generation.
Portable phototherapy beds are gaining traction as healthcare providers and families seek flexible treatment options and greater mobility.
Smart phototherapy technologies incorporating monitoring and temperature-control features are supporting more precise and comfortable neonatal care.
Growing awareness of neonatal jaundice and the importance of early treatment is increasing demand for phototherapy solutions.
Home-care models are creating opportunities for compact and portable phototherapy devices that can support treatment outside traditional hospital settings.
Manufacturers are increasingly exploring energy-efficient designs, eco-friendly materials, and connected technologies to improve device performance and reduce operational costs.
Reasons to Buy the Report:
Provides comprehensive insights into the Jaundice Phototherapy Bed Market dynamics, trends, opportunities, and growth potential.
Helps identify opportunities across neonatal jaundice, adult jaundice, and chronic jaundice applications.
Offers detailed segmentation analysis across application, type, end use, technology, and geographic markets.
Includes competitive intelligence covering leading phototherapy, medical-device, and neonatal-care companies.
Supports informed decisions using market forecasts, neonatal jaundice prevalence, technology advancements, home-care adoption, healthcare investment, and regional opportunities.
Future Outlook:
The future of the Jaundice Phototherapy Bed Market will be shaped by increasing neonatal jaundice prevalence, rising awareness of neonatal healthcare, advancements in LED phototherapy, growing demand for portable devices, and expansion of home-care treatment. Neonatal Jaundice should remain the leading application segment, with the segment projected to increase from USD 250 Million in 2024 to USD 600 Million by 2035. North America is expected to retain its leadership position, with the regional market projected to grow from USD 150 Million in 2024 to USD 360 Million by 2035. Asia Pacific is positioned for strong growth as healthcare infrastructure, neonatal-care access, and awareness of jaundice treatment improve. The global Jaundice Phototherapy Bed Market is projected to reach USD 1.2 Billion by 2035 at a CAGR of 9.1%.
➤➤Explore Our Latest Related Reports:
